<DOC>
	<DOCNO>NCT00150592</DOCNO>
	<brief_summary>The purpose study determine effect SPD503 compare placebo task sustain attention child adolescent age 6-17 diagnosed ADHD .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy SPD503 Treating ADHD Children Aged 6-17</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Subjects primary diagnosis ADHD Minimum baseline visit ADHDRSIV score 24 baseline CGIS score = &gt; 4 Male nonpregnant female subject agree comply applicable contraceptive requirement Subject weighs &gt; 55 lb morbidly overweight Subject comorbid psychiatric diagnosis ( except ODD ) significant symptom severe comorbid Axis II disorder severe Axis I disorder Subject history seizure disorder Subject specific cardiac condition family history significant cardiac condition Subject pregnant , lactate within six month postpartum</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>